Scientific Rationale for Combination Immunotherapy of Hepatocellular Carcinoma with Anti-PD-1/PD-L1 and Anti-CTLA-4 Antibodies — Masatoshi Kudo (2019) | RDL Network
Aljosja Rogiers, Florentia Dimitriou, Irene Lobón, Catriona Harvey, Ismael A. Vergara, Inês Pires da Silva, Serigne Lo, Richard A Scolyer, Matteo S. Carlino, Alexander M. Menzies, Georgina V. Long
Rebecca Simpson, Marcel Batten, Erin R. Shanahan, Mark Read, Inês Pires da Silva, Alexandra Aangelatos, Jian Tan, Chandra Mani Adhikari, Jordan W. Conway, Alex Menzies, Jonathan R. Stretch, Omgo E. Nieweg, Andrew J. Spillane, Laurence Macia, Maria Gonzales, Kerwin F. Shannon, Rebecca Velickovic, Christian U. Blank, Andrew Holmes, James S. Wilmott, Richard A Scolyer, Georgina V. Long
Discussion(0)
No comments yet. Be the first to comment.